Regeneron Pharmaceuticals (REGN) Change in Inventory (2013 - 2026)

Regeneron Pharmaceuticals' Change in Inventory history runs 14 years deep, the most recent figure standing at -$26.6 million for Q1 2026.

• On a quarterly basis, Change in Inventory fell 117.47% year-over-year to -$26.6 million in Q1 2026; TTM through Mar 2026 was $96.4 million, a 84.36% decrease from a year earlier, with the FY2025 full-year figure at $275.3 million, down 55.58% from the prior year.
• Change in Inventory eased to -$26.6 million in Q1 2026 per REGN's latest filing, from -$2.1 million in the prior quarter.
• Across five years, Change in Inventory topped out at $240.1 million in Q2 2022 and bottomed at -$26.6 million in Q1 2026.
• The 5-year median for Change in Inventory is $100.4 million (2023), against an average of $108.0 million.
• Across the five-year window, Change in Inventory surged 867.09% in 2022 and plunged 117.47% in 2026, its largest moves.
• Year by year, Change in Inventory stood at $144.3 million in 2022, then sank by 67.22% to $47.3 million in 2023, then jumped by 148.84% to $117.7 million in 2024, then tumbled by 101.78% to -$2.1 million in 2025, then plunged by 1166.67% to -$26.6 million in 2026.
• Per Business Quant, the three latest REGN Change in Inventory figures stand at -$26.6 million (Q1 2026), -$2.1 million (Q4 2025), and $82.6 million (Q3 2025).